BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27889608)

  • 1. SPOCK1 is up-regulated and promotes tumor growth via the PI3K/AKT signaling pathway in colorectal cancer.
    Zhang J; Zhi X; Shi S; Tao R; Chen P; Sun S; Bian L; Xu Z; Ma L
    Biochem Biophys Res Commun; 2017 Jan; 482(4):870-876. PubMed ID: 27889608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of SPOCK1 Inhibits the Proliferation and Invasion in Colorectal Cancer Cells by Suppressing the PI3K/Akt Pathway.
    Zhao P; Guan HT; Dai ZJ; Ma YG; Liu XX; Wang XJ
    Oncol Res; 2016 Oct; 24(6):437-445. PubMed ID: 28281964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
    Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
    Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPOCK1 promotes the proliferation, migration and invasion of glioma cells through PI3K/AKT and Wnt/β-catenin signaling pathways.
    Yang J; Yang Q; Yu J; Li X; Yu S; Zhang X
    Oncol Rep; 2016 Jun; 35(6):3566-76. PubMed ID: 27108836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
    Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
    Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of shRNA-mediated knockdown of SPOCK1 on ovarian cancer growth and metastasis.
    Zhang LQ; Wang Y; Zhang L
    Cell Mol Biol (Noisy-le-grand); 2015 Nov; 61(7):102-9. PubMed ID: 26638890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPOCK1 promotes the growth of Osteosarcoma cells through mTOR-S6K signaling pathway.
    Wang Y; Wang W; Qiu E
    Biomed Pharmacother; 2017 Nov; 95():564-570. PubMed ID: 28869894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
    Hu F; He Z; Sun C; Rong D
    Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
    Xiong B; Cheng Y; Ma L; Zhang C
    Int J Oncol; 2013 Jan; 42(1):219-28. PubMed ID: 23174819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways.
    Wei ZJ; Tao ML; Zhang W; Han GD; Zhu ZC; Miao ZG; Li JY; Qiao ZB
    Int J Clin Exp Pathol; 2015; 8(5):4481-91. PubMed ID: 26191138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PI3K/Akt pathway is involved in procyanidin-mediated suppression of human colorectal cancer cell growth.
    Choy YY; Fraga M; Mackenzie GG; Waterhouse AL; Cremonini E; Oteiza PI
    Mol Carcinog; 2016 Dec; 55(12):2196-2209. PubMed ID: 26774105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
    Wang Y; Tang Q; Li M; Jiang S; Wang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel PI3K axis selective molecule exhibits potent tumor inhibition in colorectal carcinogenesis.
    Hussain A; Qazi AK; Mupparapu N; Kumar A; Mintoo MJ; Mahajan G; Sharma PR; Singh SK; Bharate SB; Zargar MA; Ahmed QN; Mondhe DM; Vishwakarma RA; Hamid A
    Mol Carcinog; 2016 Dec; 55(12):2135-2155. PubMed ID: 26764221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor-suppressor gene LZTS1 suppresses colorectal cancer proliferation through inhibition of the AKT-mTOR signaling pathway.
    Zhou W; He MR; Jiao HL; He LQ; Deng DL; Cai JJ; Xiao ZY; Ye YP; Ding YQ; Liao WT; Liu SD
    Cancer Lett; 2015 Apr; 360(1):68-75. PubMed ID: 25667121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Odontogenic ameloblast-associated protein (ODAM) inhibits human colorectal cancer growth by promoting PTEN elevation and inactivating PI3K/AKT signaling.
    Yu M; Mu Y; Qi Y; Qin S; Qiu Y; Cui R; Zhong M
    Biomed Pharmacother; 2016 Dec; 84():601-607. PubMed ID: 27694004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. uc.338 targets p21 and cyclin D1 via PI3K/AKT pathway activation to promote cell proliferation in colorectal cancer.
    Zhang Y; Wang S; Qian W; Ji D; Wang Q; Zhang Z; Wang S; Ji B; Fu Z; Sun Y
    Oncol Rep; 2018 Aug; 40(2):1119-1128. PubMed ID: 29901203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of PTEN on the proliferation and apoptosis of colorectal cancer cells via the phosphoinositol-3-kinase/Akt pathway.
    Sun Y; Tian H; Wang L
    Oncol Rep; 2015 Apr; 33(4):1828-36. PubMed ID: 25683168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer.
    Tsai KW; Lo YH; Liu H; Yeh CY; Chen YZ; Hsu CW; Chen WS; Wang JH
    Mol Cancer; 2018 Mar; 17(1):72. PubMed ID: 29523145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.
    Hou B; Li W; Li J; Ma J; Xia P; Liu Z; Zeng Q; Zhang X; Chang D
    Oncol Rep; 2020 Feb; 43(2):536-548. PubMed ID: 31894339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.